The capabilities of DaVita Clinical Research's (DCR) Central Laboratory services have expanded.
Investments in both equipment and its 47,000-square-foot facility allow for generating a daily test volume of approximately 144,000 tests on 60,000 samples per day. DCR rate of delivery is 99.8 percent.
Each clinical project has a project manager to ensure client-specific requirements are met and communication is maintained. Data systems provide fully compliant order entry and reporting with the ability to use anywhere.
The Central Laboratory has developed green packaging for samples. The green packaging features International Air Transport Association (IATA)-compliant storage-friendly design, aiming to reduce shipping costs.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Fast Tracks Johnson & Johnson’s Nipocalimab for Fetal Neonatal Alloimmune Thrombocytopenia
March 27th 2024Johnson & Johnson is moving forward with a pair of Phase III trials of nipocalimab to reduce the risk of fetal neonatal alloimmune thrombocytopenia in alloimmunized pregnant patients.